The Cigna Group (NYSE:CI) is listed among the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. JPMorgan maintains an Overweight rating on CI after the announcement of a new model for Express Scripts commercial customers starting in 2027, eliminating rebates and introducing a point-of-sale approach.

JPMorgan analysts believe the new model addresses regulatory proposals and de-risks Express Scripts’ commercial operations. Cigna’s shift to a rebate-free default offering signals a viable approach for the broader business. CI has increased its dividend for five consecutive years, with a dividend yield of 2.02% as of October 29.

While CI is attractive for income-focused investors, certain AI stocks may offer greater upside potential and less downside risk. For an undervalued AI stock with potential benefits from Trump-era tariffs and the onshoring trend, check out the free report on the best short-term AI stock.

Disclosure: None.

Read more at Yahoo Finance: JPMorgan Maintains Overweight Rating on Cigna (CI) Following Express Scripts Update